Mark Lappe, Chief Executive Officer at Inhibrx, Inc. (INBX), sold 49,938 shares at $25.36 ($1.4M) on 2022-11-17, disclosed to the SEC on 2022-11-18.
Open-market sale of $1.4M INBX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.36 | 6,959 | $176K | 12.7% |
| 2 | $25.36 | 6,959 | $176K | 12.7% |
| 3 | $26.57 | 4,106 | $109K | 7.9% |
| 4 | $26.57 | 4,106 | $109K | 7.9% |
| 5 | $27.45 | 4,333 | $119K | 8.6% |
| 6 | $27.45 | 4,333 |
| $119K |
| 8.6% |
| 7 | $28.86 | 1,767 | $51K | 3.7% |
| 8 | $28.86 | 1,767 | $51K | 3.7% |
| 9 | $30.15 | 6,773 | $204K | 14.7% |
| 10 | $30.15 | 6,773 | $204K | 14.7% |
| 11 | $30.67 | 912 | $28K | 2.0% |
| 12 | $32.38 | 1,150 | $37K | 2.7% |
| Total | $27.73 avg | 49,938 | $1.4M | 100% |
| Filing → |
| INBX | BUY | 2024-09-10 | $671K | — | Filing → |
| INBX | BUY | 2024-09-03 | $913K | — | Filing → |
| INBX | BUY | 2024-08-22 | $1.0M | — | Filing → |